Skip to main content
Fig. 2 | Malaria Journal

Fig. 2

From: Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum

Fig. 2

Susceptibility of different P. falciparum strains to SC83288 and dihydroartemisinin. a and b Growth inhibition of NF54 and the artemisinin resistant derivative NF54ART carrying the PfK13 C580Y mutation by artemisinin (a) and SC83288 (b) in a standard cell proliferation assay with an exposure time of 72 h. c and d Growth inhibition of Dd2 and the SC83288 resistant derivative Dd2SC by artemisinin (c) and SC83288 (d). Mean ± SEM of 6–13 independent determinations

Back to article page